Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 11 » Issue 1

The lung function profile of once-daily tiotropium and olodaterol via Respimat® is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler® (ENERGITO® study)

Total article views   Abstract views HTML views PDF downloads Totals
19,919 Dovepress* 12,373 2,629+ 2,312 15,002
PubMed Central* 0 4,917 2,231 4,917
Totals 12,373 7,546 4,543 19,919
*Since 3 February 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
7 0 0 0 2 5

View citations on PubMed Central and Google Scholar